| 1 |
-
Generic vs brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children
-
12/26/2025 10:27:29 AM | Browse: 32 | Download: 154
|
| 2 |
-
Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences
-
12/25/2025 9:13:55 AM | Browse: 35 | Download: 108
|
| 3 |
-
Transient elastography and fibrosis-4 index as predictors of hepatocellular carcinoma in hepatitis C virus patients with sustained virological response
-
12/3/2025 9:10:06 AM | Browse: 51 | Download: 213
|
| 4 |
-
Overcoming barriers and expanding opportunities in liver transplantation in Mexico
-
11/19/2025 5:58:00 AM | Browse: 54 | Download: 153
|
| 5 |
-
Secular trend in universal hepatocellular carcinoma prevention: Taiwan, Poland, and Belgium experience
-
11/14/2025 12:56:13 AM | Browse: 44 | Download: 188
|
| 6 |
-
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals
-
10/27/2025 10:57:49 AM | Browse: 160 | Download: 185
|
| 7 |
-
Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis
-
9/25/2025 9:22:05 AM | Browse: 118 | Download: 216
|
| 8 |
-
Missing link: Viral RNA signatures in circulating exosomes as early diagnostic biomarkers for gastrointestinal cancers
-
9/15/2025 8:38:05 AM | Browse: 315 | Download: 195
|
| 9 |
-
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease
-
8/27/2025 9:21:09 AM | Browse: 159 | Download: 320
|
| 10 |
-
Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis
-
8/27/2025 3:44:01 AM | Browse: 139 | Download: 297
|
| 11 |
-
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs
-
6/26/2025 7:27:55 AM | Browse: 119 | Download: 477
|
| 12 |
-
Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals
-
6/23/2025 7:18:46 AM | Browse: 103 | Download: 607
|
| 13 |
-
Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients
-
6/23/2025 7:18:41 AM | Browse: 98 | Download: 570
|
| 14 |
-
Prevalence of transfusion transmissible infections among various donor groups: A comparative analysis
-
11/28/2024 3:06:30 AM | Browse: 132 | Download: 646
|
| 15 |
-
Evolution of heart transplant donor characteristics in the 21st century: A United States single center’s experience
-
7/31/2024 7:20:09 AM | Browse: 95 | Download: 504
|
| 16 |
-
Analysis of articles on hepatitis C by scientific mapping: 1989-2022
-
7/1/2024 6:03:23 AM | Browse: 192 | Download: 722
|
| 17 |
-
Ensemble for evaluating diagnostic efficacy of non-invasive indices in predicting liver fibrosis in untreated hepatitis C virus population
-
6/25/2024 9:25:52 AM | Browse: 202 | Download: 836
|
| 18 |
-
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
-
6/20/2024 3:42:22 AM | Browse: 178 | Download: 527
|
| 19 |
-
Current perspectives of viral hepatitis
-
5/11/2024 10:58:28 AM | Browse: 270 | Download: 749
|
| 20 |
-
Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis
-
3/14/2024 5:31:17 PM | Browse: 176 | Download: 965
|
| 21 |
-
Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report
-
2/27/2024 11:58:45 AM | Browse: 347 | Download: 1045
|
| 22 |
-
Metabolomics in liver diseases: A novel alternative for liver biopsy?
-
1/23/2024 9:31:44 AM | Browse: 391 | Download: 993
|
| 23 |
-
Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
-
11/24/2023 6:10:11 AM | Browse: 447 | Download: 1056
|
| 24 |
-
Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil
-
8/22/2023 7:39:26 AM | Browse: 308 | Download: 1243
|
| 25 |
-
Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports
-
7/4/2023 8:53:44 AM | Browse: 390 | Download: 1254
|
| 26 |
-
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
-
2/24/2023 1:35:50 PM | Browse: 487 | Download: 1005
|
| 27 |
-
Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States
-
2/16/2023 7:33:57 AM | Browse: 413 | Download: 1233
|
| 28 |
-
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C
-
2/10/2023 9:15:29 AM | Browse: 407 | Download: 1019
|
| 29 |
-
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
-
12/2/2022 12:50:19 PM | Browse: 508 | Download: 1650
|
| 30 |
-
Viral infections in orthopedics: A systematic review and classification proposal
-
11/16/2022 11:29:26 AM | Browse: 595 | Download: 1331
|
| 31 |
-
Analysis of hepatitis C virus positive organs in liver transplantation.
-
9/23/2022 12:48:56 AM | Browse: 537 | Download: 1285
|
| 32 |
-
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
-
8/10/2022 8:23:14 AM | Browse: 550 | Download: 1953
|
| 33 |
-
Retraction Note: Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry
-
7/27/2022 1:17:38 PM | Browse: 485 | Download: 1203
|
| 34 |
-
Hepatitis C virus burden: Treating and educating people without prejudice
-
7/27/2022 1:17:38 PM | Browse: 604 | Download: 1857
|
| 35 |
-
Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients
-
7/5/2022 8:40:56 AM | Browse: 551 | Download: 1610
|
| 36 |
-
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
-
6/23/2022 2:39:01 PM | Browse: 598 | Download: 1584
|
| 37 |
-
Relationship between the phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus
-
6/23/2022 2:39:01 PM | Browse: 520 | Download: 1402
|
| 38 |
-
Fibrosis regression following hepatitis C antiviral therapy
-
6/23/2022 2:39:01 PM | Browse: 665 | Download: 1727
|
| 39 |
-
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
-
6/23/2022 2:39:01 PM | Browse: 592 | Download: 1215
|
| 40 |
-
Metabolic aspects of hepatitis C virus
-
6/10/2022 5:40:20 AM | Browse: 663 | Download: 1542
|
| 41 |
-
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
-
6/10/2022 5:40:20 AM | Browse: 703 | Download: 1609
|
| 42 |
-
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
-
6/2/2022 12:11:47 PM | Browse: 799 | Download: 2208
|
| 43 |
-
Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral
-
5/27/2022 11:37:03 AM | Browse: 582 | Download: 1800
|
| 44 |
-
Innovations in Education: A Prospective Study of Storytelling Narratives to Enhance Hepatitis C Virus Knowledge among Substance Users
-
5/24/2022 10:35:19 AM | Browse: 495 | Download: 1445
|
| 45 |
-
Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis
-
5/19/2022 12:49:59 AM | Browse: 633 | Download: 1308
|
| 46 |
-
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020
-
5/13/2022 8:46:13 AM | Browse: 530 | Download: 1542
|
| 47 |
-
Revolution in the diagnosis and management of hepatitis C virus infection in current era
-
4/22/2022 10:52:23 AM | Browse: 753 | Download: 1904
|
| 48 |
-
Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients
-
4/6/2022 8:50:05 AM | Browse: 558 | Download: 1321
|
| 49 |
-
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
-
3/25/2022 7:42:31 AM | Browse: 691 | Download: 1601
|
| 50 |
-
Safety of Direct Acting Antiviral treatment for hepatitis C in oncologic setting: a clinical experience and a literature review.
-
3/24/2022 2:13:21 PM | Browse: 540 | Download: 1628
|
